Patents Assigned to Nordisk Rebalance A/S
  • Probiotic fermented cereal compositions and methods for treatment of gastrointestinal diseases caused by pro-inflammatory bacteria
    Patent number: 9205114
    Abstract: The invention covers a novel treatment strategy that considerably improves conventional probiotic treatments of inflammatory bowel diseases, irritable bowel syndrome and other gastrointestinal disorders. Both probiotic microorganisms and the carrier of the probiotic microorganisms in form of a fermented cereal gruel are used as treatment effectors. Phospholipids may also be an effector. The novel treatment strategy is capable of removing the symptoms of inflammatory bowel diseases regardless of a mild, moderate or severe stage of the disease.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: December 8, 2015
    Assignee: Nordisk Rebalance A/S
    Inventor: Hans Israelsen
  • Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors
    Patent number: 8900570
    Abstract: The invention covers a novel treatment strategy that considerably improves conventional probiotic treatments of inflammatory bowel diseases, irritable bowel syndrome and other gastrointestinal disorders. Both probiotic microorganisms and the carrier of the probiotic microorganisms in form of a fermented cereal gruel are used as treatment effectors. Phospholipids may also be an effector. The novel treatment strategy is capable of removing the symptoms of inflammatory bowel diseases regardless of a mild, moderate or severe stage of the disease.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: December 2, 2014
    Assignee: Nordisk Rebalance A/S
    Inventor: Hans Israelsen
  • Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors
    Patent number: 8846029
    Abstract: The invention covers a novel treatment strategy that considerably improves conventional probiotic treatments of inflammatory bowel diseases, irritable bowel syndrome and other gastrointestinal disorders. Both probiotic microorganisms and the carrier of the probiotic microorganisms in form of a fermented cereal gruel are used as treatment effectors. Phospholipids may also be an effector. The novel treatment strategy is capable of removing the symptoms of inflammatory bowel diseases regardless of a mild, moderate or severe stage of the disease.
    Type: Grant
    Filed: July 3, 2012
    Date of Patent: September 30, 2014
    Assignee: Nordisk Rebalance A/S
    Inventor: Hans Israelsen
  • Treatment of IBD and IBS Using Both Probiotic Bacteria and Fermented Cereal as Treatment Effectors
    Publication number: 20130209404
    Abstract: The invention covers a novel treatment strategy that considerably improves conventional probiotic treatments of inflammatory bowel diseases, irritable bowel syndrome and other gastrointestinal disorders. Both probiotic microorganisms and the carrier of the probiotic microorganisms in form of a fermented cereal gruel are used as treatment effectors. Phospholipids may also be an effector. The novel treatment strategy is capable of removing the symptoms of inflammatory bowel diseases regardless of a mild, moderate or severe stage of the disease.
    Type: Application
    Filed: March 14, 2013
    Publication date: August 15, 2013
    Applicant: NORDISK REBALANCE A/S
    Inventor: Nordisk Rebalance A/S
  • Treatment of IBD and IBS Using Both Probiotic Bacteria and Fermented Cereal as Treatment Effectors
    Publication number: 20130195821
    Abstract: The invention covers a novel treatment strategy that considerably improves conventional probiotic treatments of inflammatory bowel diseases, irritable bowel syndrome and other gastrointestinal disorders. Both probiotic microorganisms and the carrier of the probiotic microorganisms in form of a fermented cereal gruel are used as treatment effectors. Phospholipids may also be an effector. The novel treatment strategy is capable of removing the symptoms of inflammatory bowel diseases regardless of a mild, moderate or severe stage of the disease.
    Type: Application
    Filed: March 14, 2013
    Publication date: August 1, 2013
    Applicant: NORDISK REBALANCE A/S
    Inventor: NORDISK REBALANCE A/S
  • Treatment Of IBD And IBS Using Both Probiotic Bacteria And Fermented Cereal As Treatment Effectors
    Publication number: 20120269791
    Abstract: The invention covers a novel treatment strategy that considerably improves conventional probiotic treatments of inflammatory bowel diseases, irritable bowel syndrome and other gastrointestinal disorders. Both probiotic microorganisms and the carrier of the probiotic microorganisms in form of a fermented cereal gruel are used as treatment effectors. Phospholipids may also be an effecter. The novel treatment strategy is capable of removing the symptoms of inflammatory bowel diseases regardless of a mild, moderate or severe stage of the disease.
    Type: Application
    Filed: July 3, 2012
    Publication date: October 25, 2012
    Applicant: NORDISK REBALANCE A/S
    Inventor: Hans Israelsen
  • Treatment of Ibd and Ibs Using Both Probiotic Bacteria and Fermented Cereal as Treatment Effectors
    Publication number: 20080311097
    Abstract: The invention covers a novel treatment strategy that considerably improves conventional probiotic treatments of inflammatory bowel diseases, irritable bowel syndrome and other gastrointestinal disorders. Both probiotic microorganisms and the carrier of the probiotic microorganisms in form of a fermented cereal gruel are used as treatment effectors. Phospholipids may also be an effecter. The novel treatment strategy is capable of removing the symptoms of inflammatory bowel diseases regardless of a mild, moderate or severe stage of the disease.
    Type: Application
    Filed: September 27, 2006
    Publication date: December 18, 2008
    Applicant: Nordisk Rebalance A/S
    Inventor: Hans Israelsen